• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZIMMER GMBH ANATOMICAL SHOULDER REVERSE, SCREW SYSTEM, 4.5-18; ZIMMER TRABECULAR METAL REVERSE SHOULDER SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZIMMER GMBH ANATOMICAL SHOULDER REVERSE, SCREW SYSTEM, 4.5-18; ZIMMER TRABECULAR METAL REVERSE SHOULDER SYSTEM Back to Search Results
Model Number N/A
Device Problem Insufficient Information (3190)
Patient Problems Unspecified Infection (1930); Injury (2348)
Event Date 03/19/2009
Event Type  Injury  
Manufacturer Narrative
The manufacturer did not receive devices or x-rays for review.The product has been discarded.Where lot numbers were received for the devices, the device history records were reviewed and found to be conforming.A cause for this specific event cannot be ascertained from the information provided.Should additional information become available and an investigation result be available, that changes this assessment, an amended medical device report will be submitted.(b)(4).
 
Event Description
The event was reported in a journal article.It was reported that the patient was implanted an anatomical shoulder reverse, screw system, 4.5-18 on (b)(6) 2007 on the left side.The surgical technique was followed.On (b)(6) 2008 the patient underwent a periprosthetic debridement and mobilization the parts were left in situ.The patient was revised on (b)(6) 2009 due to periprosthetic infection with staphylococcus aureus.Journal article: "reverse total shoulder arthroplasty for failed open reduction and internal fixation of fractures of the proximal humerus", f.Grubhofer, k.Wieser, d.C.Meyer, s.Catanzaro, k.Schurholz, c.Gerber.J shoulder elbow surg.2016 aug 9.
 
Manufacturer Narrative
No trend identified.The device manufacturing quality records indicate that the released components met all requirements to perform as intended.Event description (event details, per): - event summary: in article it is mentioned that a (b)(6) female patient underwent revision surgery 9 months after index surgery due to periprosthetic staphylococcus aureus infection.The additional information received report implantation date (b)(6) 2007, had periprosthetic debridement and mobilization on (b)(6) 2008 and that the patient underwent revision surgery on (b)(6) 2009.The surgeon assures that all complications were not related to the implanted products.Review of received data - the surgical report of implantation dated (b)(6) 2007 was received for review.No conspicuousness.-the surgical notes of debridement and mobilization dated (b)(6) 2008 is available.Patient was experiencing pain and reduced range of motion, until the left shoulder has loss the functionality.It is reported that in (b)(6) 2007 the patient had a punction which showed no bacterial growing.The surgery was performed to free the joint from scar tissue.Intraoperative no evidence of infection.-the surgical report of revision dated (b)(6) 2009 was received for review.The notes states that the patient has pain and the revision it's performed to convert the inverse shoulder back to a hemi-prosthesis in order to relief patient's pain without expecting any functional improvement.Intraoperatively, scar tissue is observed and yellowish-whitish membranes are found below the inlay and the head.The membranes as well as the implants are sent for bacteriological evaluation.No other conspicuousness.-additionally, the notes of a visit dated (b)(6) 2009 are available.The notes states that the bacteriological tests evidenced of drug resistant bacteria.The patient needed to get antibiotics to combats the infection.No product was returned to zimmer biomet for in-depth analysis as they have been discarded at hospital after the removal.Root cause analysis: the gamma sterilization specification of the device certifies the suitability of sterilization.The irradiation certificate of the affected lots have been reviewed and were found to be according to specification.Therefore, it can be excluded that an unsterile device caused the infection.Moreover, no trend on infection has been observed for this product family.Therefore, it is highly unlikely that a disadvantageous product design favored or contributed to the infection.However, the ifu for endoprosthesis d011500200 states that ¿early or late infections¿ are ¿possible consequences of an implant¿ and should be considered when implanting zimmer biomet devices.There was no evidence of infection until the bacterial test performed on the materials of revision surgery on (b)(6) 2009.Additionally, the surgeon assures that all complications were not related to the implanted products.Conclusion summary: in article it is mentioned that a (b)(6) female patient underwent revision surgery 9 months after index surgery due to periprosthetic staphylococcus aureus infection.However, the received surgical notes are in contrast with the event reported in the journal article.The surgical notes state that the patient underwent a surgery after 9 months (on (b)(6) 2008), but the implants were left in situ.Twelve month after this surgery, on (b)(6) 2009, there was a conversion of the inverse shoulder back to a hemi-prosthesis (with product explantation/exchange).The gamma sterilization specification of the device certifies the suitability of sterilization.The irradiation certificate of the affected lots have been reviewed and were found to be according to specification.Therefore, it can be excluded that an unsterile device caused the infection.Moreover, no trend on infection has been observed for this product family.Therefore, it is highly unlikely that a disadvantageous product design favored or contributed to the infection.However, the ifu for endoprosthesis d011500200 states that ¿early or late infections¿ are ¿possible consequences of an implant¿ and should be considered when implanting zimmer biomet devices.There was no evidence of infection until the bacterial test performed on the materials of revision surgery on (b)(6) 2009.Additionally, the surgeon assures that all complications were not related to the implanted products.An exact root cause could not be determined.The need for corrective measures is not indicated and zimmer (b)(4) considers this case as closed.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ANATOMICAL SHOULDER REVERSE, SCREW SYSTEM, 4.5-18
Type of Device
ZIMMER TRABECULAR METAL REVERSE SHOULDER SYSTEM
Manufacturer (Section D)
ZIMMER GMBH
sulzer allee 8
sulzer industrie park
winterthur 8404
SZ  8404
Manufacturer (Section G)
ZIMMER GMBH
sulzer allee 8
sulzer industrie park
winterthur 8404
SZ   8404
Manufacturer Contact
kevin escapule
1800 west center street
warsaw, IN 46580
8006136131
MDR Report Key6063022
MDR Text Key58600295
Report Number0009613350-2016-01308
Device Sequence Number1
Product Code KWT
Combination Product (y/n)N
Reporter Country CodeSZ
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,literature
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/06/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date02/29/2012
Device Model NumberN/A
Device Catalogue Number01.04223.018
Device Lot Number2385145
Other Device ID Number00889024285972
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/06/2016
Initial Date FDA Received10/28/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received01/11/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/27/2007
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberN/A
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age53 YR
Patient Weight77
-
-